Global NGS-Based Monitoring and Diagnostic Test Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global NGS-Based Monitoring and Diagnostic Test Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.
NGS-Based Monitoring and Diagnostic Test report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global NGS-Based Monitoring and Diagnostic Test market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Out-Patient Clinics/General Practitioners and Diagnostic Centers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for NGS-Based Monitoring and Diagnostic Test industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, NGS-Based Monitoring and Diagnostic Test key companies include Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc., Beijing Genomics Institute (BGI), Cancer Genetics, Inc., CENTOGENE AG, F. Hoffmann-La Roche Ltd, GenePath Dx and Illumina, Inc., etc. Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc. are top 3 players and held % share in total in 2023.
NGS-Based Monitoring and Diagnostic Test can be divided into Commercial Assays/Tests, Laboratory Developed Tests, Direct to Consumer Test and Pre-Commercial Tests, etc. Commercial Assays/Tests is the mainstream product in the market, accounting for % share globally in 2023.
NGS-Based Monitoring and Diagnostic Test is widely used in various fields, such as Out-Patient Clinics/General Practitioners, Diagnostic Centers, Hospitals and Others, etc. Out-Patient Clinics/General Practitioners provides greatest supports to the NGS-Based Monitoring and Diagnostic Test industry development. In 2023, global % share of NGS-Based Monitoring and Diagnostic Test went into Out-Patient Clinics/General Practitioners filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global NGS-Based Monitoring and Diagnostic Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.
Segment by Type
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the NGS-Based Monitoring and Diagnostic Test market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, NGS-Based Monitoring and Diagnostic Test introduction, etc. NGS-Based Monitoring and Diagnostic Test Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of NGS-Based Monitoring and Diagnostic Test market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
NGS-Based Monitoring and Diagnostic Test report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global NGS-Based Monitoring and Diagnostic Test market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Out-Patient Clinics/General Practitioners and Diagnostic Centers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for NGS-Based Monitoring and Diagnostic Test industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, NGS-Based Monitoring and Diagnostic Test key companies include Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc., Beijing Genomics Institute (BGI), Cancer Genetics, Inc., CENTOGENE AG, F. Hoffmann-La Roche Ltd, GenePath Dx and Illumina, Inc., etc. Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc. are top 3 players and held % share in total in 2023.
NGS-Based Monitoring and Diagnostic Test can be divided into Commercial Assays/Tests, Laboratory Developed Tests, Direct to Consumer Test and Pre-Commercial Tests, etc. Commercial Assays/Tests is the mainstream product in the market, accounting for % share globally in 2023.
NGS-Based Monitoring and Diagnostic Test is widely used in various fields, such as Out-Patient Clinics/General Practitioners, Diagnostic Centers, Hospitals and Others, etc. Out-Patient Clinics/General Practitioners provides greatest supports to the NGS-Based Monitoring and Diagnostic Test industry development. In 2023, global % share of NGS-Based Monitoring and Diagnostic Test went into Out-Patient Clinics/General Practitioners filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global NGS-Based Monitoring and Diagnostic Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.
Segment by Type
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
Segment by Application
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the NGS-Based Monitoring and Diagnostic Test market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, NGS-Based Monitoring and Diagnostic Test introduction, etc. NGS-Based Monitoring and Diagnostic Test Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of NGS-Based Monitoring and Diagnostic Test market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices